Kathrin Schaal
Papers
1
Total Citations
30
H-Index
1
About
Kathrin Schaal is a leading researcher in urologic oncology, with a specialized focus on improving prostate cancer diagnostics through advanced imaging and robotic technologies. Her major contributions center on the development and validation of robot-guided, software-based transperineal MRI/TRUS fusion biopsy techniques. In her landmark 2016 study, she demonstrated the superior diagnostic accuracy of this approach in a high-risk population of previously biopsy-negative men, achieving a 30-citation impact that underscores its clinical significance. Schaal’s work directly addresses the critical challenge of detecting clinically significant prostate cancer while reducing unnecessary biopsies, offering a more precise and less invasive alternative to traditional systematic sampling. By integrating MRI targeting with robotic precision, she has helped establish a new standard for fusion biopsy protocols, particularly for patients with prior negative results. Her research not only advances personalized cancer care but also provides a reproducible framework for urologists worldwide. Schaal’s contributions are pivotal in bridging the gap between imaging innovation and clinical practice, making her a key figure in the evolution of prostate cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1